Search results
India's gray market is selling Wegovy at less than 10% of U.S. prices—even though weight-loss drugs...
Fortune· 3 days agoSuch is the interest that the anti-obesity medication market could reach $100 billion by 2030, Goldman Sachs Research said. Indians, ...
Eli Lilly hits phony drugmakers with 6 more lawsuits
Becker’s Hospital Review· 2 days agoCounterfeit versions of Eli Lilly's blockbuster GLP-1 anti-obesity medications Mounjaro and Zepound are under fire from the drugmaker ...
Taking a GLP-1 medicine? Here's what experts say you should eat
Medical Xpress· 6 days agoFolks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements...
Health panel urges interventions for children and teens with high BMI
Washington Post via Yahoo News· 3 days agoWith obesity continuing to loom as a major public health threat, a leading panel of independent U.S....
Ozempic is fueling demand for smaller clothing sizes
CBS News via Yahoo News· 2 days agoMorgan Stanley research analysts also found that survey respondents said they exercised more after starting to take anti-obesity medications< ...
Gateway - Quartz
Quartz· 3 days agoIt may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity medications, according to the pharma ...
Ozempic Frenzy Lures Rich Indians to Brave the Gray Market
Bloomberg· 3 days agoBuyers are clamoring to get drugs like Ozempic and Mounjaro, which are unavailable in India